Quaternary Ammonium-Functionalized Membrane-Anchored Photosensitizer against Multidrug-Resistant Bacterial Infections
Molecular Pharmaceutics · 03.08.2026 · 23 (8) · 4322-4332
DOI: 10.1021/acs.molpharmaceut.6c00673 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 22.07.2026. Verfasst von Yan Zeng und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Food Quality and Safety/National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical Univer…. Hauptthemen laut MEDLINE: Photosensitizing Agents, Quaternary Ammonium Compounds, Methicillin-Resistant Staphylococcus aureus, Anti-Bacterial Agents. Die Arbeit nennt 46 Literaturangaben. Gefördert von: National Key R&D Program of China, Excellent Young Foundation of Jiangsu Province, Key Science and Technology Plan Project of Lhasa.
Abstract (Originalsprache)
The discovery of new antimicrobial medications has not kept up with the evolution of bacterial resistance, and infections with drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA), continue to pose a serious threat to global public health. Antimicrobial photodynamic therapy (aPDT), as an alternative strategy, produces reactive oxygen species (ROS) under light activation and kills drug-resistant bacteria through oxidative damage. Nevertheless, conventional photosensitizers (PSs) are limited by aggregation-caused quenching, inadequate bacterial selectivity, and off-target cytotoxicity. Quaternary ammonium salts (QASs) can preferentially accumulate on bacterial membranes through electrostatic interactions and disrupt the bacterial membranes. The quaternary ammonium PS PK4, reported here has a triphenylamine unit that enhances ROS production. Under white light irradiation, PK4 produces abundant ROS that oxidatively damage bacterial membranes, while exhibiting high photostability and minimal dark toxicity. In an MRSA-infected wound model, PK4-mediated phototherapy can reduce inflammation, accelerate wound healing, and enhance collagen deposition without systemic toxicity, providing a promising aPDT strategy for combating drug-resistant bacterial infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Food Quality and Safety/National R&D Center for Chinese Herbal Medicine Processing, College of Engineering, China Pharmaceutical University, Nanjing211198, China.
- School of Engineering, China Pharmaceutical University, Nanjing211198, P. R. China.
ORCID-Profile: Chongjiang Cao, Zhenwei Yuan
Förderung
- National Key R&D Program of China
- Excellent Young Foundation of Jiangsu Province
- Key Science and Technology Plan Project of Lhasa
- Open Project of Key Laboratory of Reproductive Health Diseases Research and Translation of Ministry of Education
- Joint Program on Health Science & Technology Innovation of Hainan Province
Zitieren
APA
Zeng, Y., Tang, H., Wu, X., Lin, J., Zhang, S., Li, X., Guo, Y., Ji, T., Cao, C., & Yuan, Z. (2026). Quaternary Ammonium-Functionalized Membrane-Anchored Photosensitizer against Multidrug-Resistant Bacterial Infections. Molecular Pharmaceutics, 23(8), 4322-4332. https://doi.org/10.1021/acs.molpharmaceut.6c00673
Vancouver
Zeng Y, Tang H, Wu X, Lin J, Zhang S, Li X, et al. Quaternary Ammonium-Functionalized Membrane-Anchored Photosensitizer against Multidrug-Resistant Bacterial Infections. Molecular Pharmaceutics. 2026;23(8):4322-4332. doi:10.1021/acs.molpharmaceut.6c00673
BibTeX
@article{Zeng2026,
author = {Zeng, Yan and Tang, Hui and Wu, Xinyu and Lin, Jingjing and Zhang, Shun and Li, Xinyi and Guo, Yiwen and Ji, Tailong and Cao, Chongjiang and Yuan, Zhenwei},
title = {Quaternary Ammonium-Functionalized Membrane-Anchored Photosensitizer against Multidrug-Resistant Bacterial Infections},
journal = {Molecular Pharmaceutics},
year = {2026},
volume = {23},
number = {8},
pages = {4322--4332},
doi = {10.1021/acs.molpharmaceut.6c00673}
}
EUVIMED